tiprankstipranks
ALX Oncology Holdings (ALXO)
NASDAQ:ALXO
US Market
ALXO
ALX Oncology Holdings
RESEARCH TOOLSreports
Want to see ALXO full AI Analyst Report?

ALX Oncology Holdings (ALXO) Income Statement

443 Followers

ALX Oncology Holdings Income Statement

Last quarter (Q4 2025), ALX Oncology Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, ALX Oncology Holdings's net income was $-22.85M. See ALX Oncology Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -872.00K$ -836.00K$ 0.00$ -736.00K
Operating Expenses
$ 100.85M$ 142.47M$ 170.28M$ 127.44M$ 83.56M
Depreciation and Amortization
$ 0.00$ 872.00K$ 836.00K$ 342.00K$ 51.00K
EBITDA
$ -100.85M$ -132.25M$ -158.40M$ -122.84M$ -83.42M
Operating Income
$ -100.85M$ -142.47M$ -170.28M$ -127.44M$ -83.56M
Other Income/Expenses
$ -849.00K$ 7.62M$ 9.47M$ 4.02M$ 71.00K
Pretax Income
$ -101.69M$ -134.85M$ -160.81M$ -123.42M$ -83.48M
Net Income
$ -101.69M$ -134.85M$ -160.81M$ -123.48M$ -83.46M
Per Share Metrics
Basic EPS
$ -1.90$ -2.58$ -3.74$ -3.03$ -2.07
Diluted EPS
$ -1.90$ -2.58$ -3.74$ -3.03$ -2.07
Weighted Average Shares Outstanding
 53.66M 52.17M 42.99M 40.70M 40.31M
Weighted Average Shares Outstanding (Diluted)
 53.66M 52.17M 42.99M 40.70M 40.31M
Currency in USD

ALX Oncology Holdings Earnings and Revenue History